Stonebridge Capital Advisors LLC - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Stonebridge Capital Advisors LLC ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2023$2,550
-31.5%
22,0000.0%0.00%
Q4 2022$3,725
-6.9%
22,0000.0%0.00%
-100.0%
Q3 2022$4,000
-63.6%
22,0000.0%0.00%0.0%
Q2 2022$11,000
-15.4%
22,0000.0%0.00%0.0%
Q1 2022$13,0000.0%22,0000.0%0.00%0.0%
Q4 2021$13,000
-38.1%
22,0000.0%0.00%
-66.7%
Q3 2021$21,000
-53.3%
22,000
-50.0%
0.00%0.0%
Q2 2021$45,000
+114.3%
44,000
+100.0%
0.00%0.0%
Q1 2021$21,000
+90.9%
22,0000.0%0.00%
+50.0%
Q4 2020$11,000
-35.3%
22,0000.0%0.00%
-33.3%
Q3 2020$17,000
+41.7%
22,0000.0%0.00%
+50.0%
Q2 2020$12,000
+50.0%
22,0000.0%0.00%0.0%
Q1 2020$8,000
-46.7%
22,0000.0%0.00%0.0%
Q4 2019$15,000
-54.5%
22,000
-53.2%
0.00%
-66.7%
Q3 2019$33,000
-45.9%
47,0000.0%0.01%
-45.5%
Q2 2019$61,000
-38.4%
47,0000.0%0.01%
-38.9%
Q1 2019$99,000
-6.6%
47,0000.0%0.02%
-28.0%
Q4 2018$106,000
-7.0%
47,000
+44.6%
0.02%
+8.7%
Q3 2018$114,000
+9.6%
32,5000.0%0.02%0.0%
Q2 2018$104,000
-8.8%
32,5000.0%0.02%
-11.5%
Q1 2018$114,000
-20.3%
32,5000.0%0.03%
-21.2%
Q4 2017$143,000
-15.9%
32,5000.0%0.03%
-21.4%
Q3 2017$170,000
+18.9%
32,500
+18.2%
0.04%
+10.5%
Q2 2017$143,000
+49.0%
27,500
+22.2%
0.04%
+46.2%
Q1 2017$96,000
+95.9%
22,500
+45.2%
0.03%
+73.3%
Q4 2016$49,00015,5000.02%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q1 2020
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
Firestone Capital Management 5,200$4,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders